Literature DB >> 3735094

Prodrugs of 5-fluorouracil. V. 1-Alkoxycarbonyl derivatives as potential prodrug forms for improved rectal or oral delivery of 5-fluorouracil.

A Buur, H Bundgaard.   

Abstract

The hydrolysis and physicochemical properties of seven 1-alkoxycarbonyl derivatives of 5-fluorouracil were studied to assess their potential as prodrugs with the aim of enhancing the delivery characteristics of the parent drug. All derivatives were hydrolyzed to quantitatively yield 5-fluorouracil. The pH-rate profiles for the hydrolysis were measured. The rates of hydrolysis were markedly accelerated in the presence of plasma, affording half-lives of hydrolysis less than 4 min in 80% human plasma. The derivatives were more lipophilic than 5-fluorouracil but the aqueous solubility was only slightly reduced or, for one derivative, even greater than that of 5-fluorouracil. A preliminary absorption study in rabbits showed an absolute bioavailability of 5-fluorouracil of 100% following rectal administration of 1-(butoxycarbonyl)-5-fluorouracil as compared with no absorption following administration of 5-fluorouracil itself. The potential utility of the prodrug derivatives to enhance the oral and/or rectal delivery of the parent drug is suggested.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3735094     DOI: 10.1002/jps.2600750520

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  Prodrugs for the improvement of drug absorption via different routes of administration.

Authors:  L P Balant; E Doelker; P Buri
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Structure of 3-acetyl-5-fluorouracil (5-FU): implication for its rearrangements during hydrolysis and upon heating.

Authors:  H D Beall; R J Prankerd; L J Todaro; K B Sloan
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

3.  Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug.

Authors:  Morten Rohde; Niels M Rk; Anders E Håkansson; Klaus G Jensen; Henrik Pedersen; Tina Dige; Erling B J Rgensen; René Holm
Journal:  Results Pharma Sci       Date:  2014-05-02

4.  An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.

Authors:  W J McAuley; S A Jones; M J Traynor; S Guesné; S Murdan; M B Brown
Journal:  Eur J Pharm Biopharm       Date:  2016-03-08       Impact factor: 5.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.